Department of Pediatrics, University of Colorado Denver, Aurora, Colorado 80045, USA.
J Am Med Inform Assoc. 2010 Mar-Apr;17(2):185-91. doi: 10.1136/jamia.2009.002451.
To examine the impact of billing and clinical data extracted from an electronic medical record system on the calculation of an adverse drug event (ADE) quality measure approved for use in The Joint Commission's ORYX program, a mandatory national hospital quality reporting system.
The Child Health Corporation of America's "Use of Rescue Agents-ADE Trigger" quality measure uses medication billing data contained in the Pediatric Health Information Systems (PHIS) data warehouse to create The Joint Commission-approved quality measure. Using a similar query, we calculated the quality measure using PHIS plus four data sources extracted from our electronic medical record (EMR) system: medications charged, medication orders placed, medication orders with associated charges (orders charged), and medications administered.
Inclusion and exclusion criteria were identical for all queries. Denominators and numerators were calculated using the five data sets. The reported quality measure is the ADE rate (numerator/denominator).
Significant differences in denominators, numerators, and rates were calculated from different data sources within a single institution's EMR. Differences were due to both common clinical practices that may be similar across institutions and unique workflow practices not likely to be present at any other institution. The magnitude of the differences would significantly alter the national comparative ranking of our institution compared to other PHIS institutions.
More detailed clinical information may result in quality measures that are not comparable across institutions due institution-specific workflow, differences that are exposed using EMR-derived data.
研究从电子病历系统中提取的计费和临床数据对联合委员会 ORYX 计划中使用的药物不良事件(ADE)质量测量的计算的影响,ORYX 计划是强制性的国家医院质量报告系统。
美国儿童健康公司的“使用救援剂-ADE 触发”质量测量使用儿科健康信息系统(PHIS)数据仓库中的药物计费数据来创建联合委员会批准的质量测量。使用类似的查询,我们使用 PHIS 加从我们的电子病历(EMR)系统中提取的四个数据源计算了质量测量:计费药物、下置的药物医嘱、有相关费用的医嘱(医嘱计费)和管理的药物。
所有查询的纳入和排除标准均相同。使用五个数据集计算了分子和分母。报告的质量测量是 ADE 率(分子/分母)。
在单个机构的 EMR 中,从不同的数据源计算出了分母、分子和比率的显著差异。差异是由于可能在机构之间相似的常见临床实践和不太可能在任何其他机构存在的独特工作流程实践造成的。差异的大小将极大地改变我们机构与其他 PHIS 机构相比的国家比较排名。
由于机构特定的工作流程、使用 EMR 衍生数据暴露的差异,更详细的临床信息可能会导致质量测量在机构之间不可比。